Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG). (Q33364005)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q38291639)
(Q56432880)
(Q96038899)
(P304) 655-662
(P407) (Q1860)
(P433) 5
(P478) 22
(P577) Thursday, January 1, 2004
(P921) (Q412616)
(Q423762)
(P1433) (Q325953)
(P1476) "Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)." (language: en)
(P2093) Dimitrios Tsavdaridis
Anna Kalogera-Fountzila
Gerassimos Aravantinos
Evangelia Razis
Haralambos P Kalofonos
Pavlos Papakostas
Maria Karina
Helen Gogas
(P2860) (Q41098509)
(Q46641346)
(Q35977584)
(Q40839204)
(Q33340852)
(Q29619399)
(Q29620070)
(Q25938997)
other details
description scientific article

External Links